Skip to content

Christopher J. Langmead

2 papers in the library · 23 citations · publishing 2023

Papers

Sort Most recent Most cited

“We don’t want to run before we walk”: the attitudes of Australian stakeholders towards using psychedelics for mental health conditions

Public Health Research & Practice September 10, 2023 Breanne Kunstler, Liam Smith, Christopher J. Langmead et al. 13 citations

Objectives: This study was aimed at understanding the attitudes and positions of key Australian organisational and political stakeholders towards using psychedelic agents in medically supervised environments to treat mental health conditions. Specifically, this research was designed to identify some of the issues that might impede the clinical implementation of psychedelics. Methods:...

Molecular and structural insights into the 5‐HT2C receptor as a therapeutic target for substance use disorders

British Journal of Pharmacology September 8, 2023 Maleesha Ubhayarathna, Christopher J. Langmead, Natalie Diepenhorst et al. 10 citations

Abstract Substance use disorder (SUD) is a chronic condition, with maintained abuse of a substance leading to physiological and psychological alterations and often changes in cognitive and social behaviours. Current therapies include psychotherapy coupled with medication; however, high relapse rates reveal the shortcomings of these therapies. The signalling, expression profile, and neurological...